CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Set Your Cell And Gene Therapy Program Up For Success From Day One

  Partner with a specialized CDMO early in your CGT development to ensure a streamlined path from discovery to successful commercialization, avoiding costly pitfalls and delays.

• Automation Of 3D Intestinal Organoids Culture

  Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

• Don't Let Distribution Derail Your CGT Launch

  Overcoming distribution challenges is critical for the success of cell and gene therapies. Learn how to build a flexible, robust strategy to optimize patient access.

• Automated Library Prep For A Nanopore DNA Barcoding Protocol

  A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts.

• Key Takeaways And Market Insights From The Inaugural ThinkLive Summit

  The inaugural ThinkLive Cell and Gene Therapy Summit explored the industry’s dynamic landscape, highlighting collaboration, communication, and market access challenges.

• Key Selection Criteria For Cell & Gene Therapy CDMOs

  Choosing the right CDMO requires early internal assessment plus strong technical capability, agility, advocacy, clear communication, and long‑term alignment to meet evolving cell and gene therapy needs.

• Producing MSC-Derived Cell Therapies From Isolation To Large-Scale Expansion

  Explore the journey of producing MSC-derived cell therapies, from initial isolation and expansion to final product formulation and storage, and learn how to optimize each step.

• Studying Gut Inflammation And Barrier Disruption With Organ-On-A-Chip Technology

  See how the Colon Intestine-Chip has been employed to model cytokine-mediated inflammation and barrier disruption in the intestine.

• Scalability And Reproducibility Of The AAV9 Capture Step

  Scaling gene therapies beyond rare diseases demands innovation. Discover a chromatography system that boosts efficiency, protects product integrity, and overcomes viral vector manufacturing challenges.

• Automated NGS Solutions Advance Rare Disease Research

  See how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.